Bora Pharmaceuticals Co., LTD. completed the acquisition of TWi Pharmaceuticals, Inc.
September 31, 2022
Share
Bora Pharmaceuticals Co., LTD. (TPEX:6472) agreed to acquire TWi Pharmaceuticals, Inc. on June 14, 2022. Consideration will be paid in the form of USD 1.7196 per share.
Bora Pharmaceuticals Co., LTD. (TPEX:6472) completed the acquisition of TWi Pharmaceuticals, Inc. on September 1, 2022.
Bora Pharmaceuticals Co Ltd is a Taiwan-based company principally engaged in the agency and sales of western medicines, as well as the research, development, manufacture and sales of new drugs and health products. The Company's main products are categorized into prescription drugs and health care products, including central nervous drugs, cardiovascular drugs, antibiotics, antiviral agents, ophthalmic drugs, gastrointestinal drugs, foam ingots and health care products. In addition, the Company has biopharmaceutical technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, as well as the establishment of quality control and testing specifications and the creation of cell banks.
BORA PHARMACEUTICALS CO., LTD. 
